loader
Please Wait
Applying Filters...

Athena Athena

X

Approved Drug Products containing 50627 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 SANOFI AVENTIS US (1)

filter

01 INJECTABLE;INJECTION (1)

filter

01 RX (1)

filter

01 RIFADIN (1)

filter

01 Yes (1)

URL Supplier Web Content
INJECTABLE; INJECT...
600MG/VIAL
1989-05-25
50627
RIFADIN
RX
Yes
AP
Sanofi Company Banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier

Looking for FDA Orange Book APPLICATION 50627

Looking for FDA Orange Book APPLICATION 50627 1

19

Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

One of their notable products is RIFAMPIN, with a corresponding application number 50627.

Regulatory Information RX

With a dosage strength 600MG/VIAL

Dosage Form Route INJECTABLE; INJECTION

Reference Listed Drug Yes

Approved since 1989-05-25

Therapeutic Equivalence (TE) Code AP

Post Enquiry
POST ENQUIRY